Business
Change of Nominated Adviser and Broker
Change of Nominated Adviser and Broker.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n\n1 November 2023\n \nRua Life Sciences plc\n \n(\"RUA Life Sciences\", the \"Company\" or the \"Group\")\n \nChange of Nominated Adviser and Broker\n \nRUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, the world leading long-term implantable biostable polyurethane, announces that, following the completion of the all-share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), and as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.\n \n \nFor further information contact:\n \nRUA Life Sciences\nBill Brown, Chairman Tel: +44 (0)1294 317073 \nCaroline Stretton, Group Managing Director Tel: +44 (0)1294 317073\n \n \nCavendish Capital Markets Limited Tel: +44 (0)20 7220 0500\n(Nominated Adviser and Broker) \nGiles Balleny / Dan Hodkinson (Corporate Finance)\nMichael Johnson (Sales)\n \n \nAbout RUA Life Sciences\n \nThe RUA Life Sciences group was created in April 2020 when RUA Life Sciences Plc (formerly known as AorTech International Plc) acquired RUA Medical Devices Limited to create a fully formed medical device business. RUA Life Sciences is the holding company of the Group's four t...